Originally published by our sister publication Specialty Pharmacy Continuum
By Marcus A. Banks
A pharmacist-managed remote heart failure program that relies on data from multisensor implantable cardiac devices (ICDs) was associated with significantly reduced hospitalizations during HF treatment (Am J Health Syst Pharm 2024;81[suppl 2]:S49-S54).
The study included patients who were monitored remotely through the multisensor ICDs for at least one year after activation. The researchers compared